Tia Padia - HealthEquity Executive Officer
| HQY Stock | USD 95.68 0.59 0.62% |
Executive
Tia Padia is Executive Officer of HealthEquity
| Address | 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
HealthEquity Management Efficiency
The company has Return on Asset of 0.034 % which means that on every $100 spent on assets, it made $0.034 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0515 %, implying that it generated $0.0515 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.13 in 2024, whereas Return On Capital Employed is likely to drop 0.04 in 2024. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 51 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jason Raser | Venus Concept | N/A | |
| Finn Haley | Edwards Lifesciences Corp | N/A | |
| Anna Georgiadis | Venus Concept | 53 | |
| William Moschella | Definitive Healthcare Corp | 48 | |
| Matt Ruderman | Definitive Healthcare Corp | N/A | |
| Dirksen Lehman | Edwards Lifesciences Corp | N/A | |
| Richard CPA | Definitive Healthcare Corp | 55 | |
| Anat Kotler | Venus Concept | 40 | |
| Joyce Morris | Venus Concept | N/A | |
| Ross Portaro | Venus Concept | 60 | |
| MD FACC | Edwards Lifesciences Corp | N/A | |
| Ram Sharma | Definitive Healthcare Corp | N/A | |
| William McGrail | Venus Concept | 63 | |
| Vivian Welsh | Veeva Systems Class | N/A | |
| Daniel Lippis | Edwards Lifesciences Corp | 48 | |
| Matthew Robinson | Veeva Systems Class | 50 | |
| Joel Davis | Doximity | N/A | |
| Michele OConnor | Veeva Systems Class | 47 | |
| Arnold Pinkston | Edwards Lifesciences Corp | 65 | |
| Marc Nash | Outset Medical | 35 | |
| Andrew Dahl | Edwards Lifesciences Corp | 47 | |
Management Performance
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 |
HealthEquity Leadership Team
Elected by the shareholders, the HealthEquity's board of directors comprises two types of representatives: HealthEquity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HealthEquity. The board's role is to monitor HealthEquity's management team and ensure that shareholders' interests are well served. HealthEquity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HealthEquity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl King, Executive Officer | ||
| Elimelech Rosner, Executive CTO | ||
| Tia Padia, Executive Officer | ||
| Richard Putnam, IR Contact Officer | ||
| Larry Trittschuh, Executive Vice President Chief Security Officer | ||
| James Lucania, CFO VP | ||
| Delano JD, General VP | ||
| Jon Kessler, CEO and President and Director | ||
| Angelique Hill, Executive Vice President - Operations | ||
| Darcy Mott, CFO, Executive VP and Treasurer | ||
| Stephen Neeleman, Vice Chairman of the Board, Founder | ||
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | ||
| Brad Bennion, Senior Development | ||
| Tyson Murdock, Ex CFO | ||
| Steve Lindsay, Executive Management | ||
| Kamesh Tumsi, Senior Product |
HealthEquity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HealthEquity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 9.05 B | ||||
| Shares Outstanding | 86.66 M | ||||
| Shares Owned By Insiders | 2.06 % | ||||
| Shares Owned By Institutions | 97.94 % | ||||
| Number Of Shares Shorted | 4.18 M | ||||
| Price To Earning | 525.29 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.